BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33640757)

  • 1. The role of DNA damage response in chemo- and radio-resistance of cancer cells: Can DDR inhibitors sole the problem?
    Sadoughi F; Mirsafaei L; Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Montazer M; Hosseinpour M; Yousefi B
    DNA Repair (Amst); 2021 May; 101():103074. PubMed ID: 33640757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage response regulation by microRNAs as a therapeutic target in cancer.
    Majidinia M; Yousefi B
    DNA Repair (Amst); 2016 Nov; 47():1-11. PubMed ID: 27697364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage response and repair in pancreatic cancer development and therapy.
    Rahnamay Farnood P; Danesh Pazhooh R; Asemi Z; Yousefi B
    DNA Repair (Amst); 2021 Jul; 103():103116. PubMed ID: 33882393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaking the DNA damage response to improve cervical cancer treatment.
    Wieringa HW; van der Zee AG; de Vries EG; van Vugt MA
    Cancer Treat Rev; 2016 Jan; 42():30-40. PubMed ID: 26643553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment.
    Rozpędek W; Pytel D; Nowak-Zduńczyk A; Lewko D; Wojtczak R; Diehl JA; Majsterek I
    Curr Med Chem; 2019; 26(8):1425-1445. PubMed ID: 29345572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple kill: DDR inhibitors, radiotherapy and immunotherapy leave cancer cells with no escape.
    Qiu Y; Hu X; Zeng X; Wang H
    Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(11):1569-1576. PubMed ID: 36305726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.
    Davalli P; Marverti G; Lauriola A; D'Arca D
    Oxid Med Cell Longev; 2018; 2018():2389523. PubMed ID: 29770165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.
    Wu Z; Li S; Tang X; Wang Y; Guo W; Cao G; Chen K; Zhang M; Guan M; Yang D
    Theranostics; 2020; 10(9):3939-3951. PubMed ID: 32226530
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA damage response and repair in osteosarcoma: Defects, regulation and therapeutic implications.
    Sadoughi F; Maleki Dana P; Asemi Z; Yousefi B
    DNA Repair (Amst); 2021 Jun; 102():103105. PubMed ID: 33836418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of Response and Resistance to DNA Repair Targeted Therapies.
    Stover EH; Konstantinopoulos PA; Matulonis UA; Swisher EM
    Clin Cancer Res; 2016 Dec; 22(23):5651-5660. PubMed ID: 27678458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Targeting of DNA Damage Response in Cancer.
    Choi W; Lee ES
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.
    Curtin NJ
    Br J Pharmacol; 2013 Aug; 169(8):1745-65. PubMed ID: 23682925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.
    Darzynkiewicz Z; Traganos F; Wlodkowic D
    Eur J Pharmacol; 2009 Dec; 625(1-3):143-50. PubMed ID: 19836377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
    Kinsella TJ
    Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA damage response: implications for tumor responses to radiation and chemotherapy.
    Goldstein M; Kastan MB
    Annu Rev Med; 2015; 66():129-43. PubMed ID: 25423595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Therapeutic Application of DNA Damage Response Inhibitors against Cancer.
    Fernandes SG; Shah P; Khattar E
    Anticancer Agents Med Chem; 2022; 22(3):469-484. PubMed ID: 34102988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage response inhibitors: An avenue for TNBC treatment.
    Jin J; Tao Z; Cao J; Li T; Hu X
    Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188521. PubMed ID: 33556453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-of-the-art strategies for targeting the DNA damage response in cancer.
    Pilié PG; Tang C; Mills GB; Yap TA
    Nat Rev Clin Oncol; 2019 Feb; 16(2):81-104. PubMed ID: 30356138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting DNA repair mechanisms in cancer.
    Furgason JM; Bahassi el M
    Pharmacol Ther; 2013 Mar; 137(3):298-308. PubMed ID: 23107892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in therapeutic targeting of the DNA damage response in cancer.
    Desai A; Yan Y; Gerson SL
    DNA Repair (Amst); 2018; 66-67():24-29. PubMed ID: 29715575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.